Managing Obesity in Heart Failure: New Guidance from ACC
Sponsoring Organization: American College of CardiologyBackground and Objective: Obesity and heart failure (HF) commonly coexist. This statement
Related Articles
How Do “Pay-for-Performance” Incentives Affect Quality of Care?
“Pay-for-performance” programs have proliferated in healthcare, but their effect on quality of care is difficult to evaluate. The U.K. National Health
Risk for Stroke in Patients with Newly Diagnosed Atrial Fibrillation Who Are Hospitalized for Something Else
Atrial fibrillation (AF) often occurs in patients who are hospitalized for other causes, and it tends to resolve after underlying stressors (e.g.,
Therapeutic Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease
Sickle cell disease predisposes patients to hypercoagulability, and pulmonary microthrombosis can contribute to acute chest syndrome even if no
Switch to a SERD Before Clinical Progression in
In early trials, camizestrant, a next-generation selective estrogen receptor degrader (SERD) and complete ER antagonist, demonstrated activity in
Choosing a Long-Term Antiplatelet Regimen After PCI: A Patient-Level Meta-Analysis
For patients who undergo percutaneous coronary intervention (PCI) for coronary artery disease, the choice of antiplatelet agent for secondary
Kidney Stone Risk for Patients Who Take Common Antiepileptic Medications
Topiramate and zonisamide, originally developed as antiseizure medications, are prescribed increasingly by generalists for other uses such as obesity
Interview with Dr. Nadine Palermo and Dr. Ole-Petter Hamnvik
NEJM Group’s Dr. André Sofair checks in with the two endocrinologists who will guide our ADA meeting coverage this year: Dr. Nadine Palermo and Dr.…
Should We Add Durvalumab to Perioperative FLOT for Gastric and Gastroesophageal Cancer?
For patients with resectable gastric cancer, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) is the
Utility of Three Serum Biomarkers for Identifying Amyotrophic Lateral Sclerosis
Accurate diagnosis of amyotrophic lateral sclerosis (ALS), a relentlessly progressive neurodegenerative disease, can be challenging owing to
Rise in Euglycemic DKA Might Be Associated with SGLT-2 Inhibitor Use
Euglycemic diabetic ketoacidosis (DKA) is relatively uncommon, but its incidence seems to be increasing. Sodium–glucose cotransporter-2 (SGLT-2)